Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-383874
Filing Date
2026-09-04
Accepted
2026-09-04 18:00:03
Documents
1
Period of Report
2026-09-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7793
  Complete submission text file 0001193125-26-383874.txt   9208
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Adams Brian (Reporting) CIK: 0001636994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 261362991

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)